PT2046345E - Utilização de escina - Google Patents

Utilização de escina Download PDF

Info

Publication number
PT2046345E
PT2046345E PT77865392T PT07786539T PT2046345E PT 2046345 E PT2046345 E PT 2046345E PT 77865392 T PT77865392 T PT 77865392T PT 07786539 T PT07786539 T PT 07786539T PT 2046345 E PT2046345 E PT 2046345E
Authority
PT
Portugal
Prior art keywords
escin
Prior art date
Application number
PT77865392T
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of PT2046345E publication Critical patent/PT2046345E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
PT77865392T 2006-08-04 2007-08-03 Utilização de escina PT2046345E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06450109A EP1884245A1 (en) 2006-08-04 2006-08-04 Use of Escin

Publications (1)

Publication Number Publication Date
PT2046345E true PT2046345E (pt) 2014-12-26

Family

ID=37969918

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77865392T PT2046345E (pt) 2006-08-04 2007-08-03 Utilização de escina

Country Status (21)

Country Link
US (2) US20100227830A1 (pt)
EP (2) EP1884245A1 (pt)
JP (1) JP5345933B2 (pt)
KR (1) KR20090034946A (pt)
CN (1) CN101500582B (pt)
AU (1) AU2007280625B2 (pt)
BR (1) BRPI0715070B8 (pt)
CA (1) CA2658279C (pt)
DK (1) DK2046345T3 (pt)
EA (1) EA015404B1 (pt)
ES (1) ES2531516T3 (pt)
HR (1) HRP20141243T1 (pt)
IL (1) IL196606A (pt)
MX (1) MX2009000991A (pt)
NZ (1) NZ574249A (pt)
PL (1) PL2046345T3 (pt)
PT (1) PT2046345E (pt)
SI (1) SI2046345T1 (pt)
UA (1) UA94954C2 (pt)
WO (1) WO2008015007A2 (pt)
ZA (1) ZA200900372B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2445870T3 (es) * 2008-07-01 2014-03-05 Marinomed Biotechnologie Gmbh Biopolímeros antialérgicos marinos
EP2186523A1 (en) * 2008-11-18 2010-05-19 Marinomed Biotechnologie GmbH Use of escin for treatment of Type IV hypersensitivity reaction
ES2346844A1 (es) * 2010-03-17 2010-10-20 Ricardo Lombardero Calzon Crema para quemaduras.
WO2012101618A1 (en) 2011-01-28 2012-08-02 Barcelcom Têxteis S.A. Compression stockings and tubes with bioactive agents for the treatment of venous insufficiency and varicose veins
EP2968107B1 (en) 2013-03-15 2019-05-08 Mary Kay, Inc. Cosmetic compositions and uses thereof
KR101681857B1 (ko) 2013-11-22 2016-12-01 마리 케이 인코포레이티드 민감성 피부를 위한 조성물들
CN104147055A (zh) * 2014-07-08 2014-11-19 武汉爱民制药有限公司 赖氨酸七叶皂苷及其盐在制备治疗i型超敏反应药物中的用途
US20180154777A1 (en) * 2016-12-02 2018-06-07 Faraday&Future Inc. Braking torque blending system and method for automatic emergency braking
IT202100014495A1 (it) * 2021-06-08 2022-12-08 Neilos S R L "Composizione per l’uso nella prevenzione e/o nel trattamento di patologie osteoarticolari"

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1676561U (de) 1954-03-27 1954-05-20 Lutz Kg Maschf Eugen Vorrichtung zum fraesen von nuten u. dgl. mittels einer motor-oberfraese.
DE3402259A1 (de) * 1984-01-24 1985-08-01 Stephan Dr.med. 3000 Hannover Regöczy Therapeutisch wirksames gemisch, insbesondere zur behandlung von infektionskrankheiten im hals-, nasen- ohrenbereich, stimmbandentzuendungen, schwerer heiserkeit und trombophlebitis
DE3445324A1 (de) * 1984-12-12 1986-06-12 Klinge Pharma GmbH, 8000 München Arzneimittelkombination mit synergistischer wirkung
IT1252866B (it) 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
US6943236B2 (en) * 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6894146B1 (en) * 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) * 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6630305B1 (en) * 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) * 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) * 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
CN101500582A (zh) 2009-08-05
MX2009000991A (es) 2009-04-16
EA200900261A1 (ru) 2009-06-30
KR20090034946A (ko) 2009-04-08
ES2531516T3 (es) 2015-03-16
IL196606A0 (en) 2009-11-18
AU2007280625A1 (en) 2008-02-07
WO2008015007A3 (en) 2008-04-03
HRP20141243T1 (hr) 2015-02-13
SI2046345T1 (sl) 2015-03-31
DK2046345T3 (en) 2015-01-26
EP2046345B1 (en) 2014-12-10
JP5345933B2 (ja) 2013-11-20
US20170014465A1 (en) 2017-01-19
BRPI0715070B1 (pt) 2021-04-13
JP2009545623A (ja) 2009-12-24
EP2046345A2 (en) 2009-04-15
PL2046345T3 (pl) 2015-05-29
EP1884245A1 (en) 2008-02-06
US20100227830A1 (en) 2010-09-09
WO2008015007A2 (en) 2008-02-07
BRPI0715070A2 (pt) 2013-06-25
IL196606A (en) 2015-08-31
EA015404B1 (ru) 2011-08-30
AU2007280625B2 (en) 2012-05-17
NZ574249A (en) 2011-04-29
CA2658279C (en) 2014-10-28
ZA200900372B (en) 2009-12-30
BRPI0715070B8 (pt) 2021-05-25
CA2658279A1 (en) 2008-02-07
US9993512B2 (en) 2018-06-12
CN101500582B (zh) 2011-08-24
UA94954C2 (uk) 2011-06-25

Similar Documents

Publication Publication Date Title
AU311449S (en) Ncs-emg instrument
GB0813961D0 (en) Swab
IL196606A0 (en) Use of escin
IL197632A0 (en) Use of jam-c binding compounds
EP2097307A4 (en) INSTRUMENT
HK1129287A1 (en) Towel
GB0605107D0 (en) Use
GB0611558D0 (en) Towel
GB0624105D0 (en) Use
GB2442308B (en) Sequencer
GB0621229D0 (en) Novel use
GB0600299D0 (en) Way to go
IL192820A0 (en) Novel compounds and use thereof
AP2009004788A0 (en) Novel use
EP2022540A4 (en) INSTRUMENT SLIMMING THE JOUES
GB0617865D0 (en) Novel use
GB0603087D0 (en) Novel use
GB201114396D0 (en) Location of basesation
PL381142A1 (pl) Sposób otrzymywania glicydolu
GB0612370D0 (en) Uses of (S)-clenbuterol
TWM311768U (en) Improved structure of A-ladder
TWM301138U (en) Structure of bookmark
GB0705204D0 (en) Uses of (S)-clenbuterol
GB0618364D0 (en) Improved use of glucocorticosteroids
GB0624567D0 (en) Novel Use